Aerospan
NDC Package 0037-7590-12
Package Information
Aerospan is flunisolide is used to prevent and control symptoms (wheezing and shortness of breath) caused by asthma. Marketed by Meda Pharmaceuticals, this product is identified by NDC 0037-7590 and is authorized under FDA application NDA021247.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0037 - Meda Pharmaceuticals
- 0037-7590 - Aerospan
- 0037-7590-12 - 1 INHALER in 1 CARTON / 120 AEROSOL, METERED in 1 INHALER
- 0037-7590 - Aerospan
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0037-7590-12 identifies a specific commercial package of 1 inhaler in 1 carton / 120 aerosol, metered in 1 inhaler of Aerospan, labeled by Meda Pharmaceuticals. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Meda Pharmaceuticals on March 01, 2012. The current certification is valid through April 30, 2019.
What are the primary indications for this medication?
Flunisolide is used to prevent and control symptoms (wheezing and shortness of breath) caused by asthma. This medication belongs to a class of drugs known as corticosteroids. It works directly in the lungs to make breathing easier by reducing the irritation and swelling of the airways. This medication must be used regularly to prevent breathing problems (attacks of wheezing/shortness of breath). It does not work right away and should not be used to relieve an asthma attack. If an attack occurs, use your quick-relief inhaler as prescribed.
How is this Meda Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00037759012. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.